Global Immunotherapy Drugs Market Forecast to 2025

  • 10
    Enquiry Hours

Immunotherapy is a type of biologic therapy that stimulate or restore the ability of body’s natural defense system to fight against disease or infection. It uses materials either produced by the body or in a laboratory to enhance or reinstate immune system function. There are two types of immunotherapies — activation immunotherapies that elicit or magnify the immune response and suppression immunotherapies that reduce or suppress the immune response. They are mostly used to treat various types of immunological disorders, infections, and cancer indication (by activating immune system and generate an immune response to produce antibodies to kill tumor or cancer cells).

The Global Immunotherapy Drugs Market is driven by rising adoption of targeted therapies with less side effects, increased prevalence of lifestyle diseases, and rapid drug approval process. Increasing demand for monoclonal antibodies, adoptive T cell therapy, immune check inhibitors, and vaccines are likely to propel the growth of the immunotherapy drugs market. High treatment cost and less awareness in some regions are hampering the market growth to an extent. However, the shift from traditional chemotherapy to immunotherapy for first-line treatment and increasing opportunities in the emerging markets is anticipated to support the market growth during the forecast period.

This report provides detailed study and revenue opportunity of Immunotherapy Drugs Market across various segments such as drug type, therapy area, and region.

The Global Immunotherapy Drugs Market by drug type is segmented into monoclonal antibodies, vaccines, immune checkpoint inhibitors, interferons, interleukins, and others. Cancer, autoimmune & inflammatory diseases, infectious diseases, and others are various therapy areas of global immunotherapy drugs market.

According to Infoholic Research, the “Global Immunotherapy Drugs” market is expected to grow at a CAGR between 14% and 20%** during the forecast period 2019–2025.

The report provides details about the adoption of immunotherapy drugs across various regions including North America, Europe, Asia Pacific, and Rest of the World. The report also contains an in-depth analysis of vendor profiles, which includes financial health, business units, key business priorities, SWOT, strategies, and views of major players in the global immunotherapy drugs market.

The study offers a comprehensive analysis of the “Global Immunotherapy Drugs Market”, providing key insights of the industry. Also, the report aims to provide an opportunity for players to understand the latest trends, current market scenarios, government initiatives, and competitive landscape. In addition, it helps the venture capitalists in understanding the companies better and take informed decisions.

**Initial pre-research estimated growth range and subject to change in the final report.

Request for TOC at sales@infoholicresearch.com

Infoholic research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:

  • Data Collation (Primary & Secondary)
  • In-house Estimation (Based on proprietary data bases and Models)
  • Market Triangulation
  • Forecasting

Infoholic Research Healthcare Methodology

Market related information is congregated from both primary and secondary sources.

Primary sources involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.

Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.